The Efficacy of GLP-1 Analogues on Appetite Parameters, Gastric Emptying, Food Preference and Taste Among Adults with Obesity: Systematic Review of Randomized Controlled Trials

References

• Garvey WT, Mechanick JI, Brett EM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22:1–203. doi:10.4158/EP161365.GL
   PubMed Web of Science ®Google Scholar
• Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8(6):402–424. doi:10.1159/000442721
   PubMed Web of Science ®Google Scholar
• Ng M, Fleming T, Robinson M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980–2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2014;384(9945):766–781. doi:10.1016/S0140-6736(14)60460-8
   PubMed Web of Science ®Google Scholar
• Althumiri NA, Basyouni MH, Almousa N, et al. Obesity in Saudi Arabia in 2020: prevalence, distribution, and its current association with various health conditions. Healthc. 2021;9(3):1–8. doi:10.3390/healthcare9030311
   Google Scholar
• Kushner RF. Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis. 2014;56(4):465–472. doi:10.1016/j.pcad.2013.09.005
   PubMed Web of Science ®Google Scholar
• Erratum: Addendum. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl.1):S89–S97. doi:10.2337/dc20-ad08b
   PubMedGoogle Scholar
• Daneschvar HL, Aronson MD, Smetana GW. FDA-approved anti-obesity drugs in the United States. Am J Med. 2016;129(8):879.e1–879.e6. doi:10.1016/j.amjmed.2016.02.009
   PubMed Web of Science ®Google Scholar
• Camilleri M. Peripheral mechanisms in appetite regulation. Gastroenterology. 2015;148(6):1219–1233. doi:10.1053/j.gastro.2014.09.016
   PubMed Web of Science ®Google Scholar
• Van Bloemendaal LG, IJzerman RS, Ten Kulve J, Barkhof F. GLP-1 receptor activation modulates appetite- and reward-related brain areas in humans. Diabetes. 2014;2014:1–43.
   Google Scholar
• Abdeen GN, Miras AD, Alqahtani AR, le Roux CW. Vertical sleeve gastrectomy in adolescents reduces the appetitive reward value of a sweet and fatty reinforcer in a progressive ratio task. Surg Obes Relat Dis. 2019;15(2):194–199. doi:10.1016/j.soard.2018.10.033
   PubMed Web of Science ®Google Scholar
• Müller TD, Finan B, Bloom SR, et al. Glucagon-like peptide 1 (GLP-1). Mol Metab. 2019;30:72–130. doi:10.1016/j.molmet.2019.09.010
   PubMed Web of Science ®Google Scholar
• Pais R, Gribble FM, Reimann F. Stimulation of incretin secreting cells. Ther Adv Endocrinol Metab. 2016;7(1):24–42. doi:10.1177/2042018815618177
   PubMed Web of Science ®Google Scholar
• Holst JJ. The physiology of glucagon-like peptide 1. Physiol Rev. 2007;87(4):1409–1439. doi:10.1152/physrev.00034.2006
   PubMed Web of Science ®Google Scholar
• Horowitz M, Flint A, Jones KL, et al. Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. Diabetes Res Clin Pract. 2012;97(2):258–266. doi:10.1016/j.diabres.2012.02.016
   PubMed Web of Science ®Google Scholar
• Shah M, Vella A. Effects of GLP-1 on appetite and weight. Rev Endocr Metab Disord. 2014;15(3):181–187. doi:10.1007/s11154-014-9289-5
   PubMed Web of Science ®Google Scholar
• Flint A, Raben A, Ersbøll AK, Holst JJ, Astrup A. The effect of physiological levels of glucagon-like peptide-1 on appetite, gastric emptying, energy and substrate metabolism in obesity. Int J Obes. 2001;25(6):781–792. doi:10.1038/sj.ijo.0801627
   PubMed Web of Science ®Google Scholar
• Kadouh H, Chedid V, Halawi H, Burton DD, Clark MM, Khemani D. GLP-1 analog modulates appetite, taste preference, gut hormones and regional body fat stores in adults with obesity hoda. Cad Saude Publica. 2020;12(1):1–30.
   Google Scholar
• Blundell J, Finlayson G, Axelsen M, et al. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017;19(9):1242–1251. doi:10.1111/dom.12932
   PubMed Web of Science ®Google Scholar
• Verdich C, Flint A, Gutzwiller JP, et al. A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on Ad Libitum energy intake in humans. J Clin Endocrinol Metab. 2001;86(9):4382–4389. doi:10.1210/jc.86.9.4382
   PubMed Web of Science ®Google Scholar
• Näslund E, King N, Mansten S, et al. Prandial subcutaneous injections of glucagon-like peptide-1 cause weight loss in obese human subjects. Br J Nutr. 2004;91(3):439–446. doi:10.1079/bjn20031064
   PubMed Web of Science ®Google Scholar
• Kamioka H. Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015 statement. Japanese Pharmacol Ther. 2019;47(8):1177–1185.
   Google Scholar
• Hjerpsted JB, Flint A, Brooks A, Axelsen MB, Kvist T, Blundell J. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes Obes Metab. 2018;20(3):610–619. doi:10.1111/dom.13120
   PubMed Web of Science ®Google Scholar
• Friedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021;23(3):754–762. doi:10.1111/dom.14280
   PubMed Web of Science ®Google Scholar
• Saxena AR, Banerjee A, Corbin KD, Parsons SA, Smith SR. Energy intake as a short-term biomarker for weight loss in adults with obesity receiving liraglutide: a randomized trial. Obes Sci Pract. 2021;7(3):281–290. doi:10.1002/osp4.486
   PubMed Web of Science ®Google Scholar
• Tronieri JS, Wadden TA, Walsh O, et al. Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial. Int J Obes. 2020;44(2):353–361. doi:10.1038/s41366-019-0348-6
   Web of Science ®Google Scholar
• Van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WHM. Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. Int J Obes. 2014;38(6):784–793. doi:10.1038/ijo.2013.162
   PubMed Web of Science ®Google Scholar
• Näslund E, Gutniak M, Skogar S, Rössner S, Hellström PM. Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men. Am J Clin Nutr. 1998;68(3):525–530. doi:10.1093/ajcn/68.3.525
   PubMed Web of Science ®Google Scholar
• Näslund E, Barkeling B, King N, et al. Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men. Int J Obes. 1999;23(3):304–311. doi:10.1038/sj.ijo.0800818
   PubMed Web of Science ®Google Scholar
• Bergmann NC, Lund A, Gasbjerg LS, et al. Effects of combined GIP and GLP-1 infusion on energy intake, appetite and energy expenditure in overweight/obese individuals: a randomised, crossover study. Diabetologia. 2019;62(4):665–675. doi:10.1007/s00125-018-4810-0
   PubMed Web of Science ®Google Scholar
• Page MJ, Moher D, Bossuyt PM, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160. doi:10.1136/bmj.n160
   PubMed Web of Science ®Google Scholar
• Rate GE, Response G. Suppression of oral sweet sensations during consumption of sweet food in humans: e ff ects on; 2020.
   Google Scholar
• Douglas SM, Leidy HJ. Novel methodological considerations regarding the use of visual analog scale (VAS) appetite questionnaires in tightly controlled feeding trials. Curr Dev Nutr. 2019;3(6):1–4. doi:10.1093/cdn/nzz061
   Web of Science ®Google Scholar
• Hill AJ, Rogers PJ, Blundell JE. Techniques for the experimental measurement of human eating behaviour and food intake: a practical guide. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 1995;1995:361–375.
   Google Scholar
• Blundell J, De Graaf C, Hulshof T, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11(3):251–270. doi:10.1111/j.1467-789X.2010.00714.x
   PubMed Web of Science ®Google Scholar
• Stubbs RJ, Hughes DA, Johnstone AM, et al. The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings. Br J Nutr. 2000;84(4):405–415. doi:10.1017/s0007114500001719
   PubMed Web of Science ®Google Scholar
• Flint A, Raben A, Blundell JE, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes. 2000;24(1):38–48. doi:10.1038/sj.ijo.0801083
   PubMed Web of Science ®Google Scholar
• Secher A, Jelsing J, Baquero AF, et al. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss. J Clin Invest. 2014;124(10):4473–4488. doi:10.1172/JCI75276
   PubMed Web of Science ®Google Scholar
• Dickson SL, Shirazi RH, Hansson C, Bergquist F, Nissbrandt H, Skibicka KP. The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors. J Neurosci. 2012;32(14):4812–4820. doi:10.1523/JNEUROSCI.6326-11.2012
   PubMed Web of Science ®Google Scholar
• Medhus AW, Lofthus CM, Bredesen J, Husebye E. Gastric emptying: the validity of the paracetamol absorption test adjusted for individual pharmacokinetics. Neurogastroenterol Motil. 2001;13(3):179–185. doi:10.1046/j.1365-2982.2001.00249.x
   PubMed Web of Science ®Google Scholar
• Werner U. Effects of the GLP-1 receptor agonist lixisenatide on postprandial glucose and gastric emptying - Preclinical evidence. J Diabetes Complications. 2014;28(1):110–114. doi:10.1016/j.jdiacomp.2013.06.003
   PubMed Web of Science ®Google Scholar
• Acosta A, Camilleri M, Burton D, et al. Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study. Physiol Rep. 2015;3(11):1–10. doi:10.14814/phy2.12610
   Google Scholar
• Trahair LG, Horowitz M, Marathe CS, et al. Impact of gastric emptying to the glycemic and insulinemic responses to a 75-G oral glucose load in older subjects with normal and impaired glucose tolerance. Physiol Rep. 2014;2(11):1–10. doi:10.14814/phy2.12204
   Google Scholar
• Halawi H, Camilleri M, Acosta A, et al. Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health. Am J Physiol. 2017;313(5):G442–G447. doi:10.1152/ajpgi.00190.2017
   PubMed Web of Science ®Google Scholar
• Halawi H, Khemani D, Eckert D, et al. Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial. Lancet Gastroenterol Hepatol. 2017;2(12):890–899. doi:10.1016/S2468-1253(17)30285-6
   PubMed Web of Science ®Google Scholar